or Try an Advanced Search...

    Technical Analysis for DTIL - Precision BioSciences, Inc.

    Grade Last Price % Change Price Change
    F 7.18 0.28% 0.02
    DTIL closed up 0.28 percent on Wednesday, November 20, 2024, on 88 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical DTIL trend table...
    Date Alert Name Type % Chg
    Slingshot Bearish Bearish Swing Setup 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Gapped Up Strength 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    New 52 Week Closing Low Bearish 0.28%
    Lower Bollinger Band Walk Weakness 0.28%
    New 52 Week Low Weakness 0.28%
    Below Lower BB Weakness 0.28%
    Down 3 Days in a Row Weakness 0.28%
    Older End-of-Day Signals for DTIL ...

       Recent Intraday Alerts

    Alert Time
    Down 1% about 18 hours ago
    60 Minute Opening Range Breakdown about 18 hours ago
    Gap Up Closed about 22 hours ago
    Reversed from Up about 22 hours ago
    2x Volume Pace about 22 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    DTIL Chart by TradingView
    Basic chart:

    Profile

    Precision BioSciences is dedicated to improving life (DTIL) through its proprietary genome editing platform, “ARCUS.” Precision leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and create healthy and sustainable food and agriculture solutions. Precision is actively developing product candidates in three innovative areas: allogeneic CAR T immunotherapy, in vivo gene correction, and food.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Immunotherapy Cancer Treatment Virotherapy Human Diseases Genome Genome Editing

    Is DTIL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 15 Precision BioSciences Highlights Preclinical Data and Outlines Design of First-in-Human Clinical Trial for PBGENE-HBV for Treatment of Chronic Hepatitis B
    Nov 4 Precision BioSciences (DTIL) Reports Q3 Loss, Misses Revenue Estimates
    Nov 4 Precision BioSciences: Q3 Earnings Snapshot
    Nov 4 Precision BioSciences GAAP EPS of -$2.25, revenue of $0.6M
    Nov 4 Precision BioSciences Reports Third Quarter 2024 Financial Results and Provides Business Update
    Nov 1 Precision BioSciences Q3 2024 Earnings Preview
    Nov 1 Precision BioSciences (DTIL) Surges 6.1%: Is This an Indication of Further Gains?
    Oct 29 Precision BioSciences to Report Third Quarter Results on November 4, 2024
    Oct 28 Precision BioSciences to Host Virtual Investor Event Highlighting PBGENE-HBV Preclinical Safety Data and Phase 1 Clinical Trial Plans on November 15, 2024
    Oct 24 Precision BioSciences Presents Preclinical Data Highlighting the Capability of ARCUS for High-Efficiency Gene Editing Utilizing Homology-Directed Repair at the ESGCT 31st Annual Congress
    See more DTIL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 19.4299
    52 Week Low 7.07
    Average Volume 78,723
    200-Day Moving Average 10.65
    50-Day Moving Average 8.81
    20-Day Moving Average 8.13
    10-Day Moving Average 7.86
    Average True Range 0.41
    RSI (14) 25.37
    ADX 18.21
    +DI 16.41
    -DI 28.78
    Chandelier Exit (Long, 3 ATRs) 7.92
    Chandelier Exit (Short, 3 ATRs) 8.29
    Upper Bollinger Bands 9.10
    Lower Bollinger Band 7.16
    Percent B (%b) 0.01
    BandWidth 23.86
    MACD Line -0.41
    MACD Signal Line -0.31
    MACD Histogram -0.1046
    Fundamentals Value
    Market Cap 875.38 Million
    Num Shares 122 Million
    EPS -0.86
    Price-to-Earnings (P/E) Ratio -8.35
    Price-to-Sales 0.94
    Price-to-Book 1.60
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 7.88
    Resistance 3 (R3) 7.92 7.74 7.76
    Resistance 2 (R2) 7.74 7.56 7.71 7.72
    Resistance 1 (R1) 7.46 7.45 7.37 7.41 7.68
    Pivot Point 7.27 7.27 7.22 7.25 7.27
    Support 1 (S1) 6.99 7.09 6.90 6.95 6.68
    Support 2 (S2) 6.81 6.98 6.78 6.64
    Support 3 (S3) 6.53 6.81 6.60
    Support 4 (S4) 6.48